bpc 157 fda approval status pipeline BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded What Is BPC-157: Benefits, Uses
Description
Reported reactions include injection-site redness/itch, transient flushing and histamine-type reactions
Additionally, several trials were sponsored by industry, featuring overlapping investigator teams and manufacturer involvement in study design and data analysis
L-NAME N G -nitro-L-arginine methylester NO endothelium nitric oxide D-arginine 200 mg/kg i.v
BPC-157 at either 0.0045 mg/lb or 0.0000045 mg/lb intraperitoneally produced almost complete reversal of this supersensitivity when co-administered with haloperidol or given therapeutically afterward
